The activation of blood coagulation factor X by factor IXa is strongly stimulated by the non-enzymatic cofactors phospholipid, Ca" and activated factor VIII. In this paper we present a method by which we were able to determine binding affinities of factor IXa for phospholipids (either in the absence or presence of factor VIIIa) from kinetic measurements of factor X activation. It is shown that rates of factor X activation in the presence of phospholipids can be saturated with an excess factor VIIIa at limiting amounts of factor IXa and vice versa. Our data indicate that the enzymatic unit in the intrinsic factor X activator is a l: l stoichiometrical complex of factor IXa and factor VIIIa bound to phospholipid. Titrations with factor IXa at fixed concentrations of phospholipid and factor X show that the apparent dissociation constant of factor IXa for phospholipid is lowered from 10-6 M to 10-8 M by the presence of facto. Vttt". W" conclude, that in analogy with the role of factor Va in prothrombin activation, phospholipid-bound factor VIIIa tunctions as a high-affinity binding site ('receptor") for factor IXa in the intrinsic factor X activating complex. Therefore, factor WIIa increases the observed Vmax of factor X activation by 1) enhancing the ko, of the reaction and 2) increasing the amount of phospholipid-bound factor IXa that participates in factor X activation.
Introduc{ion
In the intrinsic pathway of the blood coagulation cascade the rymogen factor X is converted into factor Xa by the serine protease factor IXa (For a review see ref.l). The rate of factor Xa formation is strongly increased Uy itre presence of negatively charged phospholipids, Ca2+ ions and activated factor VIII (For a review on factor VIII see ref. 2) . It is thought that during factor X activation, factor IXa and VIIIa are associated in a complex adsorbed at the phospholipid surface. This complex is called the intrinsic factor X activator or the intrinsic factor X activating complex (3) (4) (5) (6) (7) . A detailed understanding of the mode of action of the intrinsic factor X activator ultimately requires quantification of the interactions between the individual components. Binding parameters, i. e. dissociation constants and number of binding sites, have been determined for interaction of factors IXa and X with phospholipid vesicles of varying composition (8, 9) . Until now no data are available, however, on interactions that involve factor VIII.
The organisation of the components of the factor X activating complex as postulated above strongly resembles the structure of the prothrombinase complex (3) (4) (5) (6) (7) (8) (9) (10) . Data on the interactions between the components of the latter complex have been obtained by several methods. One technique was to infer binding parameters from the kinetics of prothrombin activation (ll, 12).
The binding data presented in this paper, which were derived from kinetic studies of factor X activation, provide evidence that a factor IXa-factor Vllla-phospholipid complex is the catalyric unit in factor X activation and further indicate that the incorporation of factor IXa in this enzyme complex is strongly promoted by activated factor VIII.
Materials and Mcthods
Materials 52337 (Bz-Ile-Glu[Piperidyl]-Gly-Arg-pnitroanilide) was purchased from Kabi AB, Sweden; Sephacryl-S300 was from Pharmacia Sweden. Phosphatidylcholine (18 : l-l18 : 1";-phosphatidylcholine) was from Sigma Chemicals, St. [.ouis, USA; Sphingomyelin was from Koch-Light, England. All reagents were of highest grade available supplied by Merck, Darmstadt, Germany and by Sigma Chemicals, St. lruis, USA.
P hosp holipids sd ptospAotqtid Veskla
Phosphatidykxhanolamine and phosphatidylserine (both 18:1-/ 18: l";.) were prepared by cnzymatic synthesis (13) . Phospholipid vesicles were prepared by sonicatio in a buffer containing 50 mM TrisHCl and 175 mM NaCl pH 7.9 as described beforc (10) . Tbe composition of the vesicles was: 257o phcphatidylseine, ?3To phosphatidylethanolamine, 197o sphingomyelin, 28% phcphatidy'choline and cbolesterol in a 1: I molar ratio with r€spec{ to the total phocpholipid concentration.
Proteirc
Bovine facton X2, IXa and thrombin were prepared as described previously (6) . Factor VIII:C was puritred from bovine blood using the method of Vehar and Davie (fa), modifed as follows. After chromatography on sulfatesepharoce we omitted the factor X-scpharose step because factor VIII failed to bind to this @lumn. Thc final purification step for factor VIU consisted of gelfihration on Sephacryl-S3fi). Factor VIII eluted as a broad peak orresponding to the elution position of bovine catalase (1v{' 82,m). Analpis of tbe colrrmn fractions by SD$polyacrylamide gelelectrophoresis followed by silver staining showed two prcdominant bands at 250,m and 74,0m. Factor VIII stock solutions were dialyzed against a buffer contrining 10 mM morpholinoethane suffonic acid, 175 mM NaCl, 10 mM CaCl2, 10% glycerol, adjusted to pH 6.5 with I M Tris. Factor VIII was diluted in tlc same buffer containing 10 mg/ml human albumin.
Activation of Facnr YIII
Factor VIII was activated by thrombil. Optimal onditior were determined as described before by dircct mcasurcocnt of &c effect of factor VIIIa on the rate of factor X uivation (6) . In a tpicderyedncot factor WII was activated for I min at 3T C and pH 7.9 Nt a tbo.nbin concentration of 3.65 nM (130 ng/mt,0.!|6 NIH{ritYDl).
.Assav Systetn for Measurement of Factor X Activation Factor IXa and phospholipid vesicles.were prewarmed at 37" C in 0.3 ml of a buffer containing 50 mM Tris-HCl. 175 mM NaCl, l0 mM CaCll (pH 7.9). Factor X activation in the absence of facror VIIIa was started by addition of 0.2 ml prewarmed factor X. After I min and 2 min samples were taken and assaved for factor Xa using the chromogenic substrate 52337 as described before (6) . When factor VIIIa was present the activation of factor X was started by the addition of 0. I ml factor X and 0.1 ml activated factor VIII. Samples were taken,l5 s and 90 s after starting the reaction. Both in the presence and absence of factor VIIIc the formation of factor Xa was linear with time for at least 3 min.
Quantification of Factor VIII
The concentration of factor VIII was determined by a one-stage clotting assay using factor VIII deficient plasma and was expressed in unitVml. assuming the presence of I unit/ml of factor VIII in plasma pooled from 10 cows. The purified factor VIII preparation had a specific activity of 1600-3000 unitvmg in a clotting assay, assuming that A'rh ". : 10.0. It is uncertain which of the bands in the factor VIII:C preparation as seen on SDS-gels are associated with the procoagulant activity. Therefore the concentration of active factor VIII:C cannot be determined from the absorbance at 280 nm. The results presented in this paper show that the intrinsic factor X activator consists of a 1: I stoichiometrical complex of phospholipid-bound factor IXa with phospholipid-bound factor VIIIa. This enables the determination of the molar concentration of factor VIIIa on the basis of its activity in factor X activation. The method involves saturation of a limiting known amount of factor IXa with factor VIIIa, followed try saturation of a limiting unknown amount of factor VIIIa with factor IXa. When u (VIIIa) and u (IXa) are the rates of factor X activation determined for a known concentration of factor IXa saturated with factor VIIIa and for an unknown amount of factor VIIIa saturated with factor IXa, respectively, the molar factor VIIIa concentration can be calculated from the equation: The reaction conditions were as described in Fig. 1 . The concentration of factor VIIIa, when present, was 0.017 nM. u (lXa) is the rate of factor X activation at infinitely high concentration of factor IXa. KdqP is the factor IXa concentration required to obtain 0.5 u (IXa).
additional 200,000-fold rate enhancement. Kinetic analysis (6) revealed that factor VIIIa increases the Vmax of factor X activation whereas the presence of a phospholipid surface decreases the Km for factor X. These effects of accessory components on the kinetic parameters of factor X activation do explain the above mentioned rate enhancements. The drop of the Km in the presence of phospholipids is explained in a model in which phospholipids promote the formation of the enzyme-substrate complex by binding both factor IXa and factor X. The factor X and factor IXa concentrations in the presence of phospholipids can be chosen such that only factor IXa molecules which are incorporated in either factor lXa-phospholipid-or factor IXafactor Vllla-phospholipid oomplexes (factor IXa6o,n6) contribute to the rate of factor X activation (V). In that case
where c is a proportionality factor determined by the kinetic parameters of factor X activation. The dissociation constant Kd for dissociation of factor IXa from kinetically functional binding sites is given by
Results

Derivation of Binding Parameters from Kinetic Measurements
In previous studies (6) we have demonstrated that the rate of activation of factor X by factor IXa is increased in 3 orders of magnitude by negatively charged phospholipids and that the presence of the non-enzymatic protein cofactor vIIIa causes an
.,,,a 051015202530 factor lXa (nM) Fig. I . Effect of factor IXa on the rate of factor X activation in the abaence and presence of factor VIIIa. Factor IXa and phospholipid vesicles vere prewarmed at 37. C in 0.3. ml of a buffer containing 50 mM Tris-HCl, 175 mM NaCl, 10 mM CaCt , pII7.9. Factor X activation was started by additioo of 0.2 ml prewarmed factor X (panel A) or 0.1 ml of activated factor VIII plus 0.1 ml of factor X (panel B). After 60 s and 120 s (A) or 45 $ and 90 s ( B ) samples were taken and assayed for factor Xa as described in Expcrimental Procedures. The final omposition of the reaction mixtures was: factor IXa as indicated, 25 pM phospholipid, 0.5 pM factor X, 50 rnM Tris-HCl (pH 7.9), 175 mM NaCl, 6 -U C"Ctr, 0.5 mg/ml human albumin. The composition of the reaction mixtures of the experiments shown in panet B were identical to panel A, except for the presere ia B of thromtfn-actirntcd factot VIII in a frnal concentration of 0.012 otvt 1O.Ott unityml). The iffets depict double-reciprocal plos of the titration curves.
.s Fig.2. were calculated fronr the double 1/DG (nM)-l Factor Vllla (nM) Fig.3 Effect of varying amounts of activated factor VIII on the rate of faclor X activation in the presence of a limiting amount of factor IXa. Factor X activation was measured as described in the legend to Fig.18 . Factor VIII was activated at a constant conoentration of 70 UnitVml whith 3.65 nM thrombin. The final composition of the reaction mixnrc for factor X activation was: 50 mM Tris-HCl (pH 7.9), 175 mM NaCl, 6 mM CaCl3, 2.5 mg/ml ovalbunin, factor VIIIa as indicated in the The relationship between the rate of factor X activation and the concentration of factor IXa, in the presenie of phospholipids, was examined to determine whether binding parameters for factor IXa could be derived from kinetic experiments. In the two experiments shown in Fig. 1 , initial rates of factor X activation were.determined as a function of the concentration factor IXa at fixed concentrations of phospholipids vesicles (25 FM) and factor X (0.5 pM). In panel A no factor VIIIa was added and in panel B thrombin activated factor VIII was Present at a concentration of 0.012 nM (0.011 unityml). In both experiments the rate of factor X activation reached a plateau value and could, therefore, be saturated with respect to factor IXa. However the factor IXa conc€ntration required for saturation was considerably lower in the presence of factor VIIIa (B) than in is absence (A). Double-reciprocal plots of the data of Fig. 1 show a linear relationship behpeen the plotted variables. Straight lines in double-reciprocal plots are in accordance with equation IV. This expression was derived for titration of single identical binding sites with factor IXa, which upon occupation, contribute to the rate of factor X activation. As is outlined in the appendix, the formation of functional complexes containing factor IXa and factor VIIIa in a stoichiometry different from 1:1 can be ruled out. By applylng equation fV to the kinetic data, apparent Kd values for the dissociation of faclor IXa from factor lXa-phospholipid and factorlXa-factorVllla-phospholipid complexes could be calculated. The Kde found in the absence of factor VIIIa was 770 rM and in the presence of factor VIIIa 10 nM.
Additional titrations with factor IXa both in the absence and pres€nc€ of factor VIIIa were carried out at varying phospholipid and factor X concentrations. All double-reciprocal plots were linear, and binding and kinetic data calctrlated from the plots are summarized in Table 1 . It is shown that all Kdry values for factor IXa are 50-1fi) fold lowered by the prwence of factor VIIIa, indicating that factor fXa has a higher affinity for factorVllla-phospholipid complexes than for phospholipid alone. The small effects of varying phospholipid and factor X concentrations on KdEPp will be further considered in the discussion.
In the absence of factor VlIIa, thc u (Dh) values (rates of factor X activation obtained by extrapolation to infinitely hi8h concentration of factor D(a) increased at increasing phcpbolipid
concentrations. The proportional increase of u (IXa) with the phospholipid concentration is consistent with an increased number of binding sites for factor IXa available at the phospholipid surface. In the presence of factor VIIIa, u (IXa) was hardly affected by the phospholipid concentration. suggesting that under.these conditions factor VIIIa rather than phospholipid limits the total amount of facror lXa-factor Vllla-phospholipid complexes which can be formed. Both in the absence and presence of factor VIIla, decrease of the factor X concentration resulted in a decrease of u (IXa), which is due to the fact that rates of factor X activation were measured at a factor X concentration around the Km. The Km for factor X at 50 pM phospholipid was 0. 15 pM in the absence of factor VIIIa and was 0.053 pM with factor VIIIa (data not shown).
To test the suggestion that. at the phospholipid concentrations give n in Table 1 and Fig. l, factor VIIIa is the limiting componenr for the functional binding sites for factor IXa, titrations with factor IXa were carried out at four different factor VIIIa concentrations. The double-reciprocal plots obtained are shown in Fig.2 and the binding and kinetic parameters derived from these plots are summarized in Table 2 . The u (IXa) increases proportionally with the amount of factor VIIIa present. The Kd"PP is not influenced by the factor VIIIa concentration indicating that the affinity of factor IXa for functional binding sites is independent of the amount of factor VIIIa present. These results and the observation that in the presence of factor VIIIa variation of the phospholipid concentration does not affect the u (IXa), strongly suggest that in these experiments most of the factor VIIIa molecules are bound to the phospholipid bilayers where they form the catalytically functional binding sites for factor IXa.
Assembly of the Factor X Activating Complex at Increasing Factor VII Ia Concentatioru
Having shown that the rate of factor Xa formation at limiting factor VIIIa concentrations is saturable with respect to factor IXa, it was of interest to examine whether with limiting amounts of factor IXa, the rate of factor Xa formation could also be saturated with factor VIIIa. Varying amounts of activated factor VIII were added to reaction mixtures containing factor IXa, phospholipid, Ca2* and factor X. The factor IXa concentration determined by active-site titration (15) was 0.017 nM. As shown in Fig.3 , the rate of factor X activation was also saturable with factor VIIIa. The double-reciprocal plot is linear and from the intercept at the abscissae a Kd"PP of 6.7 nM is calculated for the binding of factor VIIIa to factor IXa in the presence of phospholipid. This value is in the same range as the Kd"pp values determined for factor IXa binding to phospholipids in the presence of factor VIIIa. Under the same experimental conditions (25 pM phospholipid and 0.5 pM factor X the Kd'pp for factor IXa binding to phospholipid-bound factor VIIIa is l0 nM (see Table 1 ).
Discussion
In this paper we present evidence for the hypothesis that during intrinsic factor X activation, factor IXa and factor VIIIa are complexed together at the phospholipid surface. Evidence for factor lXa-factor VIIIa interaction is provided by the observation that the rate of factor X activation is saturable with excess factor IXa in the presence of limiting amounts of factor VIIIa and vice versa. The amount of complex that is formed was proportional with the amount of limiting component present. The saturation curves were hyperbolic suggesting that single identical sites were titrated in each case . Bv titration of a limited amount of factor VIIIa with factor IXa in ih" pr"r"n"" of phospholipid a Kdupp for factor IXa between 3-16 nM was found. Titration of a limited amount of factor IXa with factor VIIIa in the presence of phospholipid resulted in a Kd"pp of 6.7 nM for factor VIIIa.
We further carried out factor X activation experiments in the absence of factor VIIIa. The Kdupp for factor IXa binding to phospholipids obtained from kinetic experiments varied between 0.4-1.1 prM. These values are comparable to binding parameters determined by Nelsestuen et al. (8) in direct binding studies. At a suboptimal Ca:* concentration they observed a Kd of 2 pM for dissociation of factor IX or RW-activated factor IX from phospholipid vesicles.
Comparison of factor X activation experiments in the absence and presence of factor VIIIa indicates that the apparent Kd for factor IXa binding is lowered 50-100 fold in the presence of factor VIIIa. We conclude that factor VIIIa functions as a high affinity binding site for factor IXa at the phospholipid surface. It is likely that the combination of factor IXa-phospholipid and factor lXa-factor VIIIa interactions promote the incorporation of factor IXa into the factor X activating complex. In that respect factor VIIIa has a similar function as factor Va in prothrombin activation. Nesheim The dependence of Kdry from the phospholipid and the factor X concentration is not completely understood. The following factors may contribute to the observed dependence: a) Up to l5"h of added factor IXa is bound, which at the higher phospholipid concentration results in somewhat higler Kd+c values b) Factor X binds to phospholipids with a Kd of 50 nM (9) and may compete with factor IXa for binding to the phospholipid surface. To appreciate the interaction of factor VIIIa with factor IXa and phospholipids it would be important to study factor VIIIa binding using a direct binding assay. Presently, however, the instabilityof activated factor VIII preparations does not allow such an approach.
In our previous experiments on the intrinsic factor X activator we used factor VIII complex consisting of factor VIII:C and von Willebrand factor (6) . In the present work we used a factor VIII:C preparation (14) that contains little or no von Willebrand factor. Using factor VIII complex, a Vmax of 5fi) moles of factor Xa min-l per mol of factor IXa was rcported, whereas in this study the Vmax value is 9fi). This result suggests that the von Willebrand factor does not strongly influence the Vmax of factor Xa formation.
The physiological implications of the high-affinity binding sites for factor IXa, formed by factor VIIIa at a lipid-or activated platelet surface appear important. The concentration of factor VIII in human plasma is 0.25 nM (unpublished observations). The concentration of factor IX, which is at least 2OGfold higher, is approximately 60 nM (16) . During the coagulation process only small amounts of factor IX are converted into factor IXa and the concentrations of factors VIIIa and IXa will remain in the nanomolar range. The 50-100 fold lowering of the Kd for factor IXa binding (to the nM range) by fac'tor VIIIa therefore allows more efficient factor lXa-factor VIIIa complex formation. Previously we found that faclor VIIIa caused a 2il),Ofi) fold enhancement of the Vmax of factor Xa formation (6) . It now appears that the overall enhanc€ment is explained by two major effects of faclor VIIIa: a) greatly enhanced catalytic power of factor lXa-Vllla-phospholipid, compared to factor Dk-phospholipid; b) enhanced factor IXa affinity for the lipid surface in the presence of factor VIIIa, which increases the amount of phospholipid-bound factor IXa that participate,r in factor X activation.
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